typical semaglutide results are in! 👏🏼😍 Our beautiful patient just completed 3 months of our medically supervised weight loss program. Over the last 90 days she has continued to exercise and eat a 📢 Coming Soon! Research Products

Research reveals that some chemotherapy-induced senescent cells may initially contribute to administration efficacy through SASP-mediated immune activation, but their persistence can promote tumor recurrence and administration resistance

medical devices

In June 2023, the FDA issued a warning that unapproved versions of GLP-1 drugs "can be risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed." The GLP-1 drug market has been dominated by pharmaceutical giant Novo Nordisk

After patients start our weight loss plan, we continue monitoring our patients and providing the dosages of Semaglutide injections weekly here at our clinic